Phase 1 study of dalotuzumab monotherapy and ridaforolimus–dalotuzumab combination therapy in paediatric patients with advanced solid tumours

Autor: Frappaz, Didier, Federico, Sara M., Pearson, Andrew D.J., Gore, Lia, Macy, Margaret E., DuBois, Steven G., Aerts, Isabelle, Iannone, Robert, Geschwindt, Ryan, Van Schanke, Arne, Wang, Rui, Geoerger, Birgit
Zdroj: In European Journal of Cancer July 2016 62:9-17
Databáze: ScienceDirect